yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q48162978-8452D48C-4D2C-47FD-99AE-3FF4731A226F
Q48162978-8452D48C-4D2C-47FD-99AE-3FF4731A226F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48162978-8452D48C-4D2C-47FD-99AE-3FF4731A226F
Systemic Treatment Options for HER2-Positive Breast Cancer Patients with Brain Metastases beyond Trastuzumab: A Literature Review.
P2860
Q48162978-8452D48C-4D2C-47FD-99AE-3FF4731A226F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48162978-8452D48C-4D2C-47FD-99AE-3FF4731A226F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d32c284193e826783ff4a24f215e9f6c5118f0fd
P2860
Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experience.